| Content Provider |
World Health Organization (WHO)-Global Index Medicus |
| Author |
Ricciardi, Maria Rosaria Ricci, Biancamaria Malgarini, Giulia Cippitelli, Marco Iannitto, Maria Luisa Soriani, Alessandra Fionda, Cinzia Morrone, Stefania Petrucci, Maria Teresa Santoni, Angela Peruzzi, Giovanna |
| Description |
Author Affiliation: Soriani A ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy); Iannitto ML ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy); Ricci B ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy); Fionda C ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy); Malgarini G ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy); Morrone S ( Department of Experimental Medicine, Sapienza University of Rome, 00161 Rome, Italy); Peruzzi G ( Center for Life Nano Science-Italian Institute of Technology Sapienza, 00161 Rome, Italy); Ricciardi MR ( Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, 00161 Rome, Italy.); Petrucci MT ( Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, 00161 Rome, Italy.); Cippitelli M ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy); Santoni A ( Department of Molecular Medicine, Pasteur Institute-Cenci Bolognetti Foundation, Sapienza University of Rome, 00161 Rome, Italy) |
| Abstract |
Increasing evidence indicates that cancer cell stress induced by chemotherapeutic agents promote antitumor immune responses and contribute to their full clinical efficacy. In this article, we identify the signaling events underlying chemotherapy-induced NKG2D and DNAM-1 ligand expression on multiple myeloma (MM) cells. Our findings indicate that sublethal doses of doxorubicin and melphalan initiate a DNA damage response (DDR) controlling ligand upregulation on MM cell lines and patient-derived malignant plasma cells in Chk1/2-dependent and p53-independent manner. Drug-induced MICA and PVR gene expression are transcriptionally regulated and involve DDR-dependent E2F1 transcription factor activity. We also describe the involvement of changes in the redox state in the control of DDR-dependent upregulation of ligand surface expression and gene transcriptional activity by using the antioxidant agent N-acetyl-L-cysteine. Finally, in accordance with much evidence indicating that DDR and oxidative stress are major determinants of cellular senescence, we found that redox-dependent DDR activation upon chemotherapeutic treatment is critical for MM cell entry in premature senescence and is required for the preferential ligand upregulation on senescent cells, which are preferentially killed by NK cells and trigger potent IFN-γ production. We propose immunogenic senescence as a mechanism that promotes the clearance of drug-treated tumor cells by innate effector lymphocytes, including NK cells. |
| ISSN |
00221767 |
| e-ISSN |
15506606 |
| Journal |
The Journal of Immunology |
| Issue Number |
2 |
| Volume Number |
193 |
| Language |
English |
| Publisher |
The American Association of Immunologists |
| Publisher Date |
2014-07-15 |
| Publisher Place |
United States |
| Access Restriction |
Open |
| Subject Keyword |
Dna Damage E2f1 Transcription Factor Immunology Killer Cells, Natural Reactive Oxygen Species Antigens, Differentiation, T-lymphocyte Metabolism Antineoplastic Agents Pharmacology Blotting, Western Cell Line, Tumor Doxorubicin Genetics Gene Expression Regulation, Neoplastic Drug Effects Histocompatibility Antigens Class I Ligands Lymphocyte Activation Melphalan Multiple Myeloma Nk Cell Lectin-like Receptor Subfamily K Receptors, Virus Reverse Transcriptase Polymerase Chain Reaction Up-regulation Research Support, Non-u.s. Gov't Discipline Immunology |
| Content Type |
Text |
| Resource Type |
Article |
| Subject |
Immunology and Allergy Immunology |
